Neurocrine Biosciences (NBIX) Misses Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $162.18 +0.35%
Revenue Growth %: +26.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +26.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.40), $0.15 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Carnival shares drop despite earnings beat on weak guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
